Skip to main content
Premium Trial:

Request an Annual Quote

Applied Markets Watch: Roche MycoTool


Roche said this week that the Canadian Health Authority has accepted the use of its PCR-based mycoplasma detection test MycoTool for release testing of an undisclosed Roche biological product.

Roche said that the test can replace conventional and time-consuming mycoplasma detection assays based on culture methods. The assay was accepted by the US Food and Drug Administration late last year for release testing of an undisclosed Roche biopharmaceutical product (PCR Insider, 12/20/2012).

Mycoplasms are frequent causes of contamination in biopharmaceutical production, cell therapy, tissue engineering and vaccine manufacturing. Traditional detection methods use growth on culture media and in vitro assays to detect contaminating organisms. These growth-based methods require as many as 28 days to complete, are laborious, and difficult to interpret, Roche said.

The MycoTool PCR kit provides all critical reagents for sample preparation and PCR. It offers sensitivity of less than 1 colony-forming unit/ml for most isolates and is compatible with a diverse spectrum of sample types including primary and continuous human cells, canine cells, nonhuman primate cells, many different rodent cell types, and cell-free matrices (culture supernatants of CHO or human stem cells, and egg-derived samples). The assay also detects the broad panel of Mollicute species due to universal primer design.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.